Report cover image

Acute Ischemic Stroke (AIS) Market, By Therapeutics (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , Online Pharmacies), By Geography (North America, Latin Ame

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 149 Pages
SKU # CMI20008025

Description

Acute ischemic stroke (AIS) is defined as the sudden loss of blood flow to an area of the brain with the consequent loss of neurological function. It is caused due to thrombotic or embolic occlusion of a cerebral artery and is more common than hemorrhagic stroke. Symptoms depend on the severity of the stroke and its location in the brain. Few people have no symptoms while Online Pharmacies only have one of the numerous symptoms. However, most people experience a combination of symptoms such as paralysis on one side of the body, changes in alertness, and changes in hearing or taste, difficulty in swallowing, dizziness or loss of balance, visual disturbances, and others.

Market Dynamics

Tobacco smoking is one of the major cause of cardiovascular disease, such as coronary heart disease, high blood pressure, heart attack, stroke, and Online Pharmacies. When a person smokes a cigarette, the blood that is distributed to the rest of the body becomes contaminated with chemicals in the smoke. These chemicals can damage the heart and blood vessels, which can lead to cardiovascular disease (CVD), the leading cause of death in the U.S. For instance, key facts provided by World Health Organization (WHO) in 2021, tobacco kills more than eight million people each year, globally. More than seven million of these deaths are due to direct tobacco use, while about 1.2 million are due to non-smokers exposed to secondhand smoke (combination of smoke from the burning end of a cigarette and the smoke breathed out by smokers). More than 80% of the world's 1.3 billion tobacco users live in low- and middle-income countries such as Bangladesh, India, Afghanistan, and Online Pharmacies.

Key features of the study:
  • This report provides in-depth analysis of the global acute ischemic stroke (AIS) market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global acute ischemic stroke (AIS) market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Boehringer Ingelheim, Bayer AG, Pfizer Inc., Biogen, Daiichi Sankyo, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, SanBio and Athersys Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global acute ischemic stroke (AIS) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute ischemic stroke (AIS) market
Detailed Segmentation:
  • Global Acute Ischemic Stroke (AIS) Market, By Therapeutics:
  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Antihypertensive
  • Global Acute Ischemic Stroke (AIS) Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Acute Ischemic Stroke (AIS) Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Hoffmann-La Roche AG
  • Boehringer Ingelheim
  • Bayer AG
  • Pfizer Inc.
  • Biogen
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • AstraZeneca
  • SanBio
  • Athersys Inc.

Table of Contents

149 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Therapeutics
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Recent Trends
Product Launches and Approvals
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER’s Analysis
4. Global Acute Ischemic Stroke (AIS) Market – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Acute Ischemic Stroke (AIS) Market, By Therapeutics, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Tissue Plasminogen Activator
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Anticoagulant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Antiplatelet
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Antihypertensive
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
6. Global Acute Ischemic Stroke (AIS) Market, By Distribution Channel, 2020 – 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast and Y-o-Y Growth, 2020 – 2032, (US$ Bn)
7. Global Acute Ischemic Stroke (AIS) Market, By Region, 2020 – 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutics, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutics, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutics, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutics, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutics, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutics, 2020 –2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 –2032, (US$ Bn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
F. Hoffmann-La Roche Ltd
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Boehringer Ingelheim International GmbH
Bayer AG
Pfizer Inc.
Biogen
DAIICHI SANKYO COMPANY, LIMITED
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
AstraZeneca
SanBio Co,Ltd.
Athersys, Inc.
Abbott
Sanofi
ZZ Biotech
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc.
NoNO Inc.
AliveCor, Inc.
Amgen Inc.
Genentech USA, Inc.
DiaMedica Therapeutics, Inc.
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 28 figures on “Global Acute Ischemic Stroke (AIS) Market,” – Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us